Health
GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial
By Adria Calatayud GSK is moving a mRNA-based vaccine candidate for seasonal flu to a late-stage clinical trial after it achieved …
Euros Today
European business & markets By Adria Calatayud GSK is moving a mRNA-based vaccine candidate for seasonal flu to a late-stage clinical trial after it achieved …

As summer vacation begins, many women are looking for hairstyles that are both stylish and comfortable—and that don't require hour…
The 20-minute test aims to help clinicians identify sepsis hours earlier than conventional lab workflows.